Sarraf Pasha — SEC Form 4 filings

SEC reporting owner CIK 2059447. 5 Form 4 filings on record with FilingPulse; latest filed 2026-08-28.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-03-12 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cue Biopharma, Inc. (CUE)Director55 legs · 323,857 sh · $99,7474

Form 4 filings — Sarraf Pasha

FiledFormIssuerReported transactionsSource
2026-08-284/ACue Biopharma, Inc. (CUE)Grant/award (A): 18,400 @ $0EDGAR
2026-07-104Cue Biopharma, Inc. (CUE)Grant/award (A): 21,800 @ $0EDGAR
2026-01-064Cue Biopharma, Inc. (CUE)Grant/award (A): 24,400 (derivative) @ $0EDGAR
2026-01-024Cue Biopharma, Inc. (CUE)Purchase (P): 4,229 @ $0.31 · Purchase (P): 77,148 @ $0.30 · Purchase (P): 86,947 @ $0.32 · Purchase (P): 78,116 @ $0.31 · Purchase (P): 77,417 @ $0.30EDGAR
2025-03-124Cue Biopharma, Inc. (CUE)Grant/award (A): 48,800 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2059447 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →